SciMax
SciMax Global LLC is a Princeton, NJ-based SaaS subsidiary of Techsol Corporation that sells a unified Medical Affairs platform (SCIMAX) — covering medical information, publications, grants, IIT, expanded access, and an agentic AI layer (ARIN) — to pharmaceutical, biotech, and rare disease companies globally.
- Company typePrivate
- Founded-
- HeadquartersPrinceton, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SciMax does
SciMax Global LLC is a Princeton, NJ-based SaaS provider focused exclusively on Scientific Communications and Medical Affairs technology for the pharmaceutical and life sciences industry. The company operates as a privately-held subsidiary of Techsol Corporation (doing business as Techsol Life Sciences). SciMax sells a unified, purpose-built cloud platform (SCIMAX) composed of six specialized modules — Medical Information (MI), Publication Planning (PUBS), Sponsored Trials Management (IIT), Grants Management, Expanded Access Management (EAP), and a Collaborative Engagement Portal (CP) — typically licensed as enterprise subscriptions with modular adoption.
The product architecture is built on .NET and Angular, runs on Oracle/MS SQL/MySQL databases, and deploys across AWS and Azure cloud infrastructure. On top of this platform the company has layered SCIMAX ARIN, an agentic AI offering launched in 2025 that combines generative AI with intelligent automation. SCIMAX ARIN powers 10+ specialized AI agents covering inquiry triage and case processing, adverse event/product complaint dispatch, content recommendation and response package composition, retrospective and predictive quality assurance, medical information chatbots, plain language summary generation, and journal/congress suggestion. The platform integrates with enterprise CRMs and Veeva Vault (PromoMats/MedComms), and SciMax maintains an unusually deep compliance posture — ISO 27001, ISO 13485, ISO 14155, ISO 9001, HIPAA, GDPR, and EU-US Data Privacy Framework — relevant to regulated life sciences buyers.
SciMax makes money through annual enterprise SaaS subscriptions (quote-based, modular pricing for SCIMAX MI, PUBS, GRANTS, CP and the AI agents) and through professional services for platform onboarding and Medical Affairs process consulting. Go-to-market is direct enterprise field sales targeting Top 50 pharmaceutical innovators, mid-sized firms, orphan drug and emerging biotech companies, medical information contact centers, and agencies. Demand generation is layered through industry event sponsorship (MAPS, ISMPP, DIA, World Patient Safety Congress), content marketing, paid search, and the proprietary SCIMAX Connect customer forum, which is scheduled for Boston in July 2026. Operations extend from Princeton, NJ to a delivery/technical hub in Hyderabad, India, with regulatory reach into the UK, Ireland, Germany, and South Korea for data processing. Named customers include JAMP Pharma Group, Knight Therapeutics, and an undisclosed rare-disease biopharma; MAPS is a Principal Partner with 15,000+ members from 280+ companies.
SciMax firmographics
Firmographics- Name
- SciMax
- Legal name
- SciMax Global LLC
- Website
- https://scimaxglobal.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SciMax Global LLC is a Princeton, NJ-based SaaS subsidiary of Techsol Corporation that sells a unified Medical Affairs platform (SCIMAX) — covering medical information, publications, grants, IIT, expanded access, and an agentic AI layer (ARIN) — to pharmaceutical, biotech, and rare disease companies globally.
- Ownership category
- akta.pro rank
SciMax industry classification
Industry- Product category
- Medical Affairs SaaS Platform
- NAICS
- Software Publishers (5132), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
- akta.pro secondary industries
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)
Keywords
Where SciMax is headquartered
LocationHeadquarters
- HQ city
- Princeton
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SciMax business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscriptions: SciMax generates revenue primarily through SaaS platform subscriptions for their Medical Affairs software suite. The platform is offered as a cloud-based solution with configurable components, role-based access, and continuous enhancements. Pricing is likely based on enterprise agreements with modular components for different Medical Affairs functions.
- Professional Services: Platform on-boarding and Medical Affairs process consulting services are offered, including enterprise software implementation, configuration, and domain expertise in strategizing, planning, and executing Medical Affairs projects.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS Platform - Custom pricing based on organizational requirements |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
SciMax product offering
Product offeringCore offering
SciMax Global provides a unified, cloud-based SaaS platform purpose-built for Medical Affairs operations in the pharmaceutical and life sciences industry. Its portfolio covers medical information inquiry management, publication planning, grants and expanded access program administration, and investigator-initiated trial management, augmented by the SCIMAX ARIN agentic AI layer for content generation, inquiry triage, and process automation. The company also offers implementation and Medical Affairs process consulting services alongside its software.
Product overview
SciMax offers a unified SaaS platform for Medical Affairs with multiple specialized products and AI-powered agents. The core platform includes SCIMAX MI (Medical Inquiry Management), SCIMAX PUBS (Publication Planning), SCIMAX GRANTS, SCIMAX IIT (Investigator-Initiated Trials), SCIMAX EAP (Expanded Access), and SCIMAX CP (Collaborative Engagement Portal). These are complemented by SCIMAX ARIN, an agentic AI layer that powers multiple specialized AI agents including Inquiry Triage & Case Processing, Retrospective QA, Content Recommendation & Fulfilment, Smart Chatbots, Plain Language Generation, and Journal & Congress Suggester. Professional Services include platform on-boarding and Medical Affairs process consulting.
Differentiator
Problem solved
Functional benefit
Products and services
- SCIMAX MI (Medical Information)
Companies that use SciMax
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
SciMax technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature11 records
SciMax partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered principal partner and core.
- MAPS (Medical Affairs Professional Society)principal partnerMAPS is the premier non-profit global Medical Affairs organization with over 15,000+ members from 280+ companies globally. SciMax is a Principal Partner, collaborating to transform the Medical Affairs profession and increase its value to patients, HCPs, industry and society.
- PhactMIcorePhactMI is a collaboration of pharmaceutical company Medical Information leaders dedicated to supporting healthcare professionals. SciMax is a Corporate Partner, working together to support quality patient care through medical information excellence.
- ISMPP (International Society for Medical Publication Professionals)coreISMPP is the global authority on ethical and effective communication of medical research with more than 2,600 members worldwide. SciMax participates in ISMPP events and academy programs.
- DIA (Drug Information Association)coreDIA is a global association that mobilizes life science professionals from across all areas of expertise. SciMax participates in DIA MedComms and Medical Affairs and Scientific Communications Forum events.
- Techsol Life Sciences (Parent Company)coreTechsol Life Sciences is the parent company of SciMax Global. Techsol provides data processing infrastructure and operates as the data controller for certain personal data processing activities. SciMax operates as the SaaS subsidiary focused on Medical Affairs.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
SciMax competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA offers a broad portfolio across clinical, commercial, and Medical Affairs technology and services, including technology platforms for Medical Information and scientific communications. It is a broad incumbent rather than a Medical Affairs specialist, but competes for the same enterprise pharma wallet.
Direct peers
- Envision Pharma Group: Envision is a long-established Medical Affairs and publications services + technology provider (including Datavision publications software) that competes with SciMax PUBS and adjacent medical communications offerings, particularly for pharma publication planning.
- Complete HealthVizion: Complete HealthVizion (CHV) is a medical communications and scientific publications agency with proprietary technology, competing with SciMax PUBS and SCIMAX Platform Services in publications planning and scientific content delivery for pharma.
- Veeva Systems: Veeva is the dominant life sciences CRM and content management vendor; its Vault PromoMats / MedComms products directly overlap with SciMax's SCIMAX MI and SCIMAX PUBS modules, and Veeva CRM competes in adjacent Medical Affairs workflows. It is the most relevant direct competitor given SciMax already integrates with Vault PromoMats/MedComms.
- Within3: Within3 provides a client management and HCP engagement platform widely used by Medical Affairs teams for advisory boards, MSL interactions, and insight management — overlapping with SciMax's Collaborative Engagement Portal (SCIMAX CP) and MSL lookup use cases.
- Ashfield MedComms (Inizio Medical): Ashfield MedComms, now part of Inizio Medical, is a leading medical communications and publications agency serving pharma Medical Affairs, directly overlapping with SciMax PUBS and platform services for scientific content planning and dissemination.
- MMS (Medical Marketing Solutions): MMS provides clinical and regulatory services with proprietary data and content technology serving pharma medical and regulatory affairs, partially overlapping with SciMax's regulatory-grade Medical Information and submissions-oriented offerings.
Emerging players
- Trial Library: Trial Library is an emerging clinical-trial feasibility and site intelligence platform with partial overlap into Medical Affairs workflows. It is comparable as a niche SaaS targeting pharma operations teams but does not directly compete in Medical Information or publications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
SciMax social profiles
Digital presenceSciMax compliance and trust
Trust signalCompliance7 records
SciMax financial estimates
Financial estimateRevenue estimate
Valuation estimate
SciMax leadership team
Management profileNumber of profiles
Profiles7 records
SciMax funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SciMax M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SciMax
What does SciMax do?
SciMax Global provides a unified, cloud-based SaaS platform purpose-built for Medical Affairs operations in the pharmaceutical and life sciences industry. Its portfolio covers medical information inquiry management, publication planning, grants and expanded access program administration, and investigator-initiated trial management, augmented by the SCIMAX ARIN agentic AI layer for content generation, inquiry triage, and process automation. The company also offers implementation and Medical Affairs process consulting services alongside its software.
Is SciMax a public or private company?
SciMax is a private company. It is classified as corporate owned and is currently operating.
When was SciMax founded?
SciMax was founded in -1. It employs 11 to 50 people.
Where is SciMax based?
SciMax is headquartered in Princeton, United States, in the North America region.
How does SciMax make money?
Two revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are professional Services.
Who are SciMax's main competitors?
IQVIA is listed as a broad incumbent. Direct peers are Envision Pharma Group, Complete HealthVizion, Veeva Systems, Within3, Ashfield MedComms (Inizio Medical) and MMS (Medical Marketing Solutions). Trial Library is listed as an emerging player.
Does SciMax have an API?
No public API is recorded for SciMax.
What industry is SciMax in?
SciMax's product category is Medical Affairs SaaS Platform. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7372.